Logo

    universal screening

    Explore " universal screening" with insightful episodes like "Empowering Patients With Education on HBV: Sharing Session 2", "Hepatitis Delta in Focus: Episode 1 of Answering the Questions on Screening, Diagnosis, and Treatment", "Season 1, Episode 7:Implementing Universal Chlamydia Screening for Young Women ages 16-21 in a Pediatric Primary Care Setting", "Universal Screening for Hepatitis Delta" and "The Lancet Psychiatry: October 08, 2014" from podcasts like ""CCO Infectious Disease Podcast", "CCO Infectious Disease Podcast", "Just US: Before, Birth, and Beyond", "CCO Infectious Disease Podcast" and "The Lancet Psychiatry in conversation with"" and more!

    Episodes (5)

    Empowering Patients With Education on HBV: Sharing Session 2

    Empowering Patients With Education on HBV: Sharing Session 2

    In this episode, Robert Wong, MD, MS, and a patient discuss opportunities to optimize care for people living with hepatitis B virus (HBV), including:

    • Opportunities to improve patient education, including education for expectant mothers with HBV
    • Potential cultural considerations that may result in delayed HBV diagnosis and care 
    • Stigma reduction with universal HBV screening and vaccination
    • Strategies to improve patient education (eg, online resources, advocacy groups, use of layman’s terms and diagrams, repetition)

    Presenter: 

    Robert Wong, MD, MS 
    Clinical Associate Professor 
    Division of Gastroenterology and Hepatology
    Stanford University School of Medicine
    Palo Alto, California

    Content based on an online CME program supported by an independent educational grant from Gilead Sciences, Inc.

    Link to full program: 
    https://bit.ly/49TuZ8U

    Get access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify.

    Hepatitis Delta in Focus: Episode 1 of Answering the Questions on Screening, Diagnosis, and Treatment

    Hepatitis Delta in Focus: Episode 1 of Answering the Questions on Screening, Diagnosis, and Treatment

    In this episode, Maria Buti, MD, and Richard H. Davis, PA-C, address key considerations when screening, diagnosing, and treating patients with hepatitis delta virus (HDV), such as:

    • Barriers to screening 
    • HDV screening based on patient risk factors 
    • Universal screening for all patients with positive hepatitis B surface antigen (HBsAg)
    • Reflex testing 
    • Availability of commercial testing
    • Monitoring suggestions in HBsAg positive and HDV antibody positive patients with negative HDV RNA
    • Limitations to evaluating advanced fibrosis in patients with HDV
    • Data on novel HDV therapies (eg, bulevirtide and lonafarnib)
    • Extending HDV therapy (eg, peginterferon) based on treatment response
    • Stopping rules (eg, HDV RNA negativity, HBsAg loss) for discontinuing HDV therapy

    Faculty:

    Maria Buti, MD
    Professor of Medicine
    Hospital Universitario Vall d’Hebron
    Barcelona, Spain

    Richard H. Davis, PA-C
    Senior PA
    Gastroenterology
    University of Florida
    UF Health
    Gainesville, Florida

    Link to full program: 
    http://bit.ly/3yp1Lxf

    Season 1, Episode 7:Implementing Universal Chlamydia Screening for Young Women ages 16-21 in a Pediatric Primary Care Setting

    Season 1, Episode 7:Implementing Universal Chlamydia Screening for Young Women ages 16-21 in a Pediatric Primary Care Setting

    Speaker: Ari Zadel, MD

    Description: Listen in this week as we speak with Dr. Ari Zadel, MD, a pediatrician right here in Western North Carolina. Dr. Zadel discusses the importance of universal chlamydia screening as well as some operational ways to start screening in your practice. 

    If you liked what you heard please share with your network and complete our survey! 

    https://redcap.mahec.net/redcap/surveys/?s=XTM8T3RPNK

    Show Notes: 

    http://chlamydiacoalition.org/for-healthcare-providers/why-screen-for-chlamydia/

    https://californiaptc.com/resources/university-of-michigan-chlamydia-screening-starter-guide/ 

    https://rhntc.org


    Please provide feedback here:
    https://redcap.mahec.net/redcap/surveys/?s=XTM8T3RPNK

    Universal Screening for Hepatitis Delta

    Universal Screening for Hepatitis Delta

    Hepatitis delta is the most severe form of viral hepatitis, and many patients remain undiagnosed. In this episode, Maria Buti, MD, and Robert G. Gish, MD, discuss the prevalence and severity of hepatitis delta. Hear their personal experiences from the clinic and their call to action for universal screening of patients with hepatitis B for coinfection with hepatitis delta.

    Presenters:
    Maria Buti, MD
    Professor of Medicine
    Hospital Universitario Vall d'Hebron
    Barcelona, Spain

    Robert G. Gish, MD
    Professor of Medicine
    Loma Linda University
    Loma Linda, California
    Medical Director
    Hepatitis B Foundation
    Washington, DC

    Link to full program:
    https://bit.ly/3E9xKSx

    The Lancet Psychiatry: October 08, 2014

    The Lancet Psychiatry: October 08, 2014

    Should healthcare workers go back to school? Niall Boyce discusses mental health interventions in schools with Series author Mina Fazel.

    Continue this conversation on social!
    Follow us today at...
    https://twitter.com/thelancet
    https://instagram.com/thelancetgroup
    https://facebook.com/thelancetmedicaljournal
    https://linkedIn.com/company/the-lancet
    https://youtube.com/thelancettv